Early Use of Iloprost in Nonfreezing Cold Injury

      Nonfreezing cold injury (NFCI) is caused by prolonged exposure to cold, usually wet conditions and represents a separate pathological entity from frostbite. The pathophysiology of NFCI is characterized by vasoconstriction and microcirculatory disturbance. Iloprost, a synthetic prostaglandin analogue with vasodilatory properties is a recognized adjuvant treatment in frostbite; however, its role in NFCI is unclear. We present a case of a 29-y-old man with severe NFCI to both forefeet after prolonged immersion in cold seawater. Initial treatment with passive rewarming, analgesia and aspirin was initiated. Infusion of iloprost was used within 24 h from presentation and was well tolerated. This resulted in reduced tissue loss compared to the apparent tissue damage documented during the initial assessment. Delayed surgical intervention allowed minor debridement and minor toe amputations, maintaining the patient’s ability to ambulate. This case demonstrates the safe use of iloprost in acute NFCI and highlights the importance of delayed surgical intervention in patients presenting with severe NFCI.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Wilderness & Environmental Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Imray C.H.
        • Richards P.
        • Greeves J.
        • Castellani J.W.
        Nonfreezing cold-induced injuries.
        J R Army Med Corps. 2011; 157: 79-84
        • Imray C.H.
        • Handford C.
        • Thomas O.D.
        • Castellani J.W.
        Nonfreezing cold injuries.
        in: Auerbach P.S. Cushing T.A. Harris S. Auerbach's Wilderness Medicine. 7th ed. Elsevier, London2016: 222-234
        • Sachs C.
        • Lehnhardt M.
        • Daigeler A.
        • Goertz O.
        The triaging and treatment of cold-induced injuries.
        Dtsch Arztebl Int. 2015; 112: 741-747
        • Cauchy E.
        • Cheguillaume B.
        • Chetaille E.
        A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite.
        N Engl J Med. 2011; 364: 189-190
        • Musiał J.
        • Wilczyńska M.
        • Sładek K.
        • Cierniewski C.S.
        • Nizankowski R.
        • Szczeklik A.
        Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease.
        Prostaglandins. 1986; 31: 61-70
        • McIntosh S.E.
        • Freer L.
        • Grissom C.K.
        • Auerbach P.S.
        • Rodway G.W.
        • Cochran A.
        • et al.
        Wilderness Medical Society clinical practice guidelines for the prevention and treatment of frostbite: 2019 update.
        Wilderness Environ Med. 2019; 30: S19-S32
        • Ionescu A.-M.
        • Huchinson S.
        • Ahmad M.
        • Imray C.
        Potential new treatment for non-freezing cold injury: is iloprost the way forward?.
        J R Army Med Corps. 2017; 163: 361-363
        • Kuht J.A.
        • Woods D.
        • Hollis S.
        Case series of non-freezing cold injury: epidemiology and risk factors.
        J R Army Med Corps. 2019; 165: 400-404
        • Imray C.H.
        • Grieve A.
        • Dhillon S.
        Cold damage to the extremities: frostbite and non-freezing cold injuries.
        Postgrad Med J. 2009; 85: 481-488
        • Heil K.
        • Thomas R.
        • Robertson G.
        • Porter A.
        • Milner R.
        • Wood A.
        Freezing and non-freezing cold weather injuries: a systematic review.
        Br Med Bull. 2016; 117: 79-93